References
- Montesano-GesualdiNChiricoGCataneseMTPirozziGEspositoFAROS-29 is involved in adaptive response to oxidative stressFree Radic Res200640546747616551573
- BlackHSde GruijlFRForbesPDPhotocarcinogenesis: an overviewJ Photochem Photobiol B199740129479301042
- HueiRNetaPChemistry of reactive oxygen speciesGilbertDLColtonCAReactive oxygen species in biological systems: An interdisciplinary approachNew YorkSpringer20023373
- PortugalMBarakVGinsburgIKohenRInterplay among oxidants, antioxidants, and cytokines in skin disorders: present status and future considerationsBiomed Pharmacother200761741242217604942
- Scharffetter-KochanekKWlaschekMBrenneisenPSchauenMBlaudschunRWenkJUV-induced reactive oxygen species in photocarcinogenesis and photoagingBiol Chem199737811124712579426184
- TrenamCWBlakeDRMorrisCJSkin inflammation: reactive oxygen species and the role of ironJ Invest Dermatol19929966756821469283
- AfaqFAdhamiVMAhmadNPrevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless miceToxicol Appl Pharmacol20031861283712583990
- van GinkelPRSareenDSubramanianLResveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondriaClin Cancer Res200713175162516917785572
- MehnertWMäderKSolid lipid nanoparticles: production, characterization and applicationsAdv Drug Deliv Rev2001472–316519611311991
- MüllerRHMäderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm200050116117710840199
- JenningVGohlaSHEncapsulation of retinoids in solid lipid nano-particles (SLN)J Microencapsul200118214915811253932
- WissingSAMüllerRHMantheiLMayerCStructural characterization of Q10-loaded solid lipid nanoparticles by NMR spectroscopyPharm Res200421340040515070088
- MüllerRHRungeSRavelliVMehnertWThunemannAFSoutoEBOral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystalsInt J Pharm20063171828916580159
- KüchlerSWolfNBHeilmannS3D-wound healing model: influence of morphine and solid lipid nanoparticlesJ Biotechnol20101481243020138929
- DinglerABlumRPNiehusHMüllerRHGohlaSSolid lipid nano-particles (SLN/Lipopearls) – a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal productsJ Microencapsul199916675176710575627
- PugliaCFilosaRPedutoAEvaluation of alternative strategies to optimize ketorolac transdermal deliveryAAPS Pharm Sci Technol20067364
- SoutoEBWissingSABarbosaCMMüllerRHDevelopment of a controlled release formulation based on SLN and NLC for topical clotrimazole deliveryInt J Pharm20042781717715158950
- TeeranachaideekulVMüllerRHJunyaprasertVBEncapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC) – effects of formulation parameters on physicochemical stabilityInt J Pharm20073401–219820617482778
- PardeikeJHommossAMüllerRHLipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal productsInt J Pharm20093661–217018418992314
- TeskacKKristlJThe evidence for solid lipid nanoparticles mediated cell uptake of resveratrolInt J Pharm20103901616919833178
- GokceEHSandriGBonferoniMCCyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicityInt J Pharm20083641768618725276
- JangJHSurhYJProtective effects of resveratrol on hydrogen peroxide-induced apoptosis in rat pheochromocytoma (PC12) cellsMutation Res20014961–218119011551494
- AfzalMMatsugoBAoyamaKTakeuchiTMethod to overcome photoreaction, a serious drawback to the use of dichlorofluorescin in evaluation of reactive oxygen speciesBiochem Biophys Res Commun2003304461962412727198
- ŠenyiğitTSonvicoFBarbieriSÖzerÖSantiPColomboPLecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skinJ Control Rel20101423368673
- TimmsREFractional crystallization – the fat modification process for the 21st centuryEur J Lipid Sci Technol20051074857
- IllingworthDFractionation of fatsMarangoniAGNarineSSPhysical Properties of LipidsNew YorkMarcel Dekker2002411477
- JenningVThünemannAFGohlaSHCharacterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipidsInt J Pharm2000199216717710802410
- UnerMYenerGImportance of solid lipid nanoparticles (SLN) in various administration routes and future perspectivesInt J Nanomedicine20072328930018019829
- KaurIPKapilaMAgrawalRRole of novel delivery systems in developing topical antioxidants as therapeutics to combat photoageingAgeing Res Rev20076427128817933593
- SoutoEBMullerRHNanoparticulate drug delivery systemsInforma Healthcare U S A, Inc2007166213234
- TrombinoSCassanoRMuzzalupoRPingitoreACioneEPicciNStearyl ferulate-based solid lipid nanoparticles for the encapsulation and stabilization of beta-carotene and alfa-tocopherolColloids Surf B Biointerfaces200972218118719410436
- RuktanonchaiUBejraphaPSakulkhuUPhysicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic acidAAPS Pharm Sci Tech2009101227234
- CullisPRChonnASempleSCInteractions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behaviour in vivoAdv Drug Delivery Rev1998321–2317
- HayesMEDrummondDCHongKIncreased target specificity of anti-HER2 genospheres by modification of surface charge and degree of PEGylationMol Pharm2006367263617140260
- WesołowskaOKuzdzałMStrancarJMichalakKInteraction of the chemopreventive agent resveratrol and its metabolite, piceatannol, with model membranesBiochim Biophys Acta2009178891851186019527681